Dublin, July 24, 2017 -- The "Global Topical Drug Delivery Market - Trends and Forecast to 2024" report has been added to Research and Markets' offering.
Global Topical Drug Delivery Market is Expected to Reach USD 194.2 Billion by 2024, at a CAGR 9.3% During the Forecast Period of 2017 to 2024
Topical drug delivery involves the introduction of a medication to the body surface such as skin or mucous membrane or to the circulatory system by periodic transdermal drug delivery for the treatment of diseases. It is considered as key route for local and systemic treatment. Drugs delivered through this route of administration penetrate deeply into the skin and are better absorbed. Topical drugs such as sunscreens and astringents are used for prophylaxis.
They are used in the treatment of skin conditions such as bacterial, fungal, and viral infections; inflammation; pruritus; corns; warts; and other dermatologic conditions. Also products such as transdermal patches provide systemic drug delivery non-invasively. Topical drug delivery includes liquid, semi-solid, solid, and transdermal patches and gels.
Key Topics Covered:
1 Introduction
1.1. Overview of the Global Topical Drug Delivery Market
1.2. Market Segmentation & Coverage
1.2.1. Currency and Pricing
1.2.2. Limitation
1.2.3. Stakeholders
2 Research Methodology
2.1. Key Takeaways
2.2. Arriving at the Global Topical Drug Delivery Market Size
2.2.1. Market Crackdown Approach
2.2.2. Company Revenue and Market Share Analysis
2.2.3. Data Triangulation
2.2.4. Key Data Points from Primary Sources
2.2.5. Product Pipeline Analysis
2.2.6. Porter's Five Forces Matrix
2.4. Global Topical Drug Delivery Market: Research Snapshot
2.5. Assumptions
3 Market Landscape Summary
4 Premium Insights
4.1. Overview
4.2. Global Topical Drug Delivery Market: Key Primary Insights
4.3. Market Overview
4.3.1. Drivers
4.3.1.1. Rising Prevalence of Chronic Disease Such as Diabetes
4.3.1.2. Growth in Transdermal Technology
4.3.1.3. Innovation and Development of New Drug Types
4.3.1.4. Better Healthcare Spending in South Asia and Africa
4.3.2. Restraints
4.3.3. Opportunities
4.3.4. Threats
4.4. Key Market Trends and Upcoming Technologies
5 Executive Summary
6 Topical Drug Delivery Market, by Product Type
6.1. Overview
6.2. Topical Drug Delivery, by Product Type
6.2.1. Transdermal Drug Delivery Devices, by Product Type
6.2.1.1. Transdermal Patches
6.2.1.2. Transdermal Gels
6.2.2. Topical Drug Delivery Formulations, by Form
6.2.2.1. Liquid Topical Drug Delivery Formulations, by Type
6.2.2.1.1. Solutions
6.2.2.1.2. Suspensions
6.2.2.2. Semi-Solid Topical Drug Delivery Formulations, by Type
6.2.2.2.1. Gels
6.2.2.2.2. Creams
6.2.2.2.3. Ointments
6.2.2.2.4. Pastes
6.2.2.2.5. Lotions
6.2.2.3. Solid Topical Drug Delivery Formulations, by Type
6.2.2.3.1. Suppositories
6.2.2.3.2. Powders
7 Topical Drug Delivery Market, by End-User
7.1. Overview
7.2. Hospitals
7.3. Home Healthcare
7.4. Clinics
7.5. Diagnostic Centers
7.6. Others
8 Topical Drug Delivery Market, by Distribution Channel
8.1. Overview
8.2. Hospital Pharmacies
8.3. Pharmacy Stores
8.4. Direct Tenders
8.5. Online Pharmacy
9 Topical Drug Delivery Market, by Geography
10 Topical Drug Delivery Market: Competitive Landscape
11 Topical Drug Delivery Market, Company Profiles
- 3M Drug Delivery Systems
- Antares Pharma Inc.
- Biofarmitalia S.R.L
- Crescita Therapeutics
- Easton Pharmaceuticals Inc.
- Endo Pharmaceuticals Inc.
- Galderma S.A.
- Hisamitsu Pharmaceutical Co. Inc.
- Janssen Pharmaceuticals Inc. (A J&J Company)
- Lohmann Therapie-Systeme AG
- Mylan Pharmaceuticals Inc.
- Nitto Denko Corporation
- Pharmatek Laboratories Inc.
- Prosollus Pharmaceuticals
- Samyang Biopharmaceuticals Corporation
- Sheffield Pharmaceuticals Inc.
- Solvay
- Stiefel Laboratories Inc.
- Tapemark
- Therasolve NV
- Transdermal Technologies Inc.
- Valeant Pharmaceuticals International Inc.
For more information about this report visit https://www.researchandmarkets.com/research/f3cx57/global_topical
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Drug Delivery


Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Apple Turns 50: From Garage Startup to AI Crossroads
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
UPS and Teamsters Reach Agreement to Limit Driver Severance Program
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions 



